{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:15:51Z","timestamp":1781298951593,"version":"3.54.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168376","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T13:40:30Z","timestamp":1482241230000},"page":"e0168376","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-6267","authenticated-orcid":true,"given":"Luca","family":"Prosperini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"de Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Scarpazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Moiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Cosottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Gerevini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Italian PML study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"D Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/CMR.05031-11","article-title":"Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain","volume":"25","author":"MW Ferenczy","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","article-title":"Persistence and pathogenesis of the neurotropic polyomavirus JC","volume":"77","author":"HS Wollebo","year":"2015","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13550280390195298","article-title":"The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology","volume":"9","author":"P Cinque","year":"2003","journal-title":"J Neurovirol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"L Kappos","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/practneurol-2011-000092","article-title":"Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring","volume":"12","author":"D Hunt","year":"2012","journal-title":"Pract Neurol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/WCO.0b013e328360279f","article-title":"Progressive multifocal leukoencephalopathy in patients with multiple sclerosis","volume":"26","author":"KJ Baldwin","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against \u03b14\u03b21 integrin","volume":"356","author":"TA Yednock","year":"1992","journal-title":"Nature"},{"issue":"16","key":"ref9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1212\/WNL.0b013e3182a84101","article-title":"Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis","volume":"81","author":"C Warnke","year":"2013","journal-title":"Neurology"},{"key":"ref10","unstructured":"hcp.biogen-international.com\/tysabri_update.aspx?ID = 22076 (accessed 30 June 2016)."},{"key":"ref11"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"T Plavina","year":"2014","journal-title":"Ann Neurol"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"IL Tan","year":"2011","journal-title":"Neurology"},{"issue":"20","key":"ref14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1212\/WNL.0b013e31821a446b","article-title":"Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"P Vermersch","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000200","article-title":"Neurological immune reconstitution inflammatory response: riding the tide of immune recovery","volume":"28","author":"DB Clifford","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.0b013e31826846b4","article-title":"The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?","volume":"79","author":"R Phan-Ba","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acn3.114","article-title":"Outcome and survival of asymptomatic PML in natalizumab-treated MS patients","volume":"1","author":"T Dong-Si","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s13365-015-0316-4","article-title":"Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"21","author":"T Dong-Si","year":"2015","journal-title":"J Neurovirol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/jnnp-2015-311411","article-title":"MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS","volume":"87","author":"MP Wattjes","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp-2013-304986","article-title":"Punctuate pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?","volume":"84","author":"MP Wattjes","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"ref21","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"JR Berger","year":"2013","journal-title":"Neurology"},{"key":"ref22"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10072-010-0469-0","article-title":"Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group\u2014Italian Neurological Society","volume":"32","author":"A Ghezzi","year":"2011","journal-title":"Neurol Sci"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis","volume":"37","author":"A Traboulsee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC virus antibodies: implications for PML risk stratification","volume":"68","author":"L Gorelik","year":"2010","journal-title":"Ann Neurol"},{"issue":"Suppl 4","key":"ref27","first-page":"27","article-title":"Imaging findings for PML in natalizumab-treated MS patients","volume":"18","author":"ND Richert","year":"2012","journal-title":"Mult Scler"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long term disability in patients with initial findings suggestive of multiple sclerosis","volume":"61","author":"A Minneboo","year":"2004","journal-title":"Arch Neurol"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","article-title":"Progressive multifocal leukoencephalopathy complication HIV-1 infection","volume":"9","author":"P Cinque","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis- establishing disease prognosis and monitoring patients","volume":"11","author":"MP Wattjes","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"18","key":"ref31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/WNL.0b013e318253d61e","article-title":"Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS","volume":"78","author":"S Gheuens","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/1352458513481010","article-title":"Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab","volume":"19","author":"M Blinkenberg","year":"2013","journal-title":"Mult Scler"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.clinthera.2016.01.010","article-title":"Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases","volume":"38","author":"R N'gbo N'gbo Ikazabo","year":"2016","journal-title":"Clin Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"CS Tan","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"72","author":"TA Yousry","year":"2012","journal-title":"Ann Neurol"},{"issue":"S1","key":"ref36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13550280390195315","article-title":"Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful of beneficial?","volume":"9","author":"RA Du Pasquier","year":"2003","journal-title":"J Neurovirol"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"DB Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref38","article-title":"Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy","author":"R Hoepner","year":"2016","journal-title":"Mult Scler"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jnnp-2014-308630","article-title":"MRI pattern in asymptomatic natalizumab-associated PML","volume":"86","author":"MP Wattjes","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/jamaneurol.2013.1960","article-title":"Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab","volume":"70","author":"AL Boster","year":"2013","journal-title":"JAMA Neurol"},{"issue":"2","key":"ref41","first-page":"117","article-title":"Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group","volume":"87","author":"C McGuigan","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00415-008-0767-0","article-title":"Variations in functioning and disability in multiple sclerosis. A two-year prospective study","volume":"255","author":"C Ytterberg","year":"2008","journal-title":"J Neurol"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/acn3.301","article-title":"Diagnostic delay in progressive multifocal leukoencephalopathy","volume":"3","author":"DP Miskin","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.0000000000002330","article-title":"Age as a potential risk factor for PML. Response to \u201cGagne Brosseau MS, Stobbe G, Wundes A. Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay","volume":"86","author":"D Ontaneda","year":"2016","journal-title":"Neurology"},{"issue":"Pt 5","key":"ref45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/brain\/123.5.1027","article-title":"Kurtzke scales revisited: the application of psychometric methods to clinical intuition","volume":"123","author":"J Hobart","year":"2000","journal-title":"Brain"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T08:51:13Z","timestamp":1540198273000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168376"}},"subtitle":[],"editor":[{"given":"Orhan","family":"Aktas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168376","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}